These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 651964)

  • 1. Hypercalcemia and increases in serum hormone value during prolonged administration of 1alpha,25-dihydroxyvitamin D.
    Bell NH; Stern PH
    N Engl J Med; 1978 Jun; 298(22):1241-3. PubMed ID: 651964
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypercalcemia during long-term treatment with 1,25-dihydroxyvitamin D3 in hypoparathyroidism.
    Bell NH; Epstein S; Stern PH
    N Engl J Med; 1979 Nov; 301(21):1183-4. PubMed ID: 492291
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.
    Bell NH; Stern PH; Pantzer E; Sinha TK; DeLuca HF
    J Clin Invest; 1979 Jul; 64(1):218-25. PubMed ID: 312811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha-hydroxyvitamin D3 in the long-term management of hypoparathyroidism and pseudohypoparathyroidism.
    Lewin IG; Papapoulos SE; O'Riordan JL
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():203s-207s. PubMed ID: 606417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D.
    Barbour GL; Coburn JW; Slatopolsky E; Norman AW; Horst RL
    N Engl J Med; 1981 Aug; 305(8):440-3. PubMed ID: 6894783
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
    Kooh SW; Fraser D; DeLuca HF; Holick MF; Belsey RE; Clark MB; Murray TM
    N Engl J Med; 1975 Oct; 293(17):840-4. PubMed ID: 170516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter: 1,25-Dihydroxyvitamin D3 and pseudohypoparathyroidism.
    Sinha TK; Bell NH
    N Engl J Med; 1976 Mar; 294(11):612. PubMed ID: 1246249
    [No Abstract]   [Full Text] [Related]  

  • 8. 24,25-Dihydroxyvitamin D3 administration increases incidence of parturient paresis.
    Barton BA; Hodnett DW; Jorgensen NA; DeLuca HF
    J Dairy Sci; 1984 Jun; 67(6):1236-9. PubMed ID: 6611359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is calcitriol [1,25(OH)2D3] harmful to renal function?
    Massry SG; Goldstein DA
    JAMA; 1979 Oct; 242(17):1875-6. PubMed ID: 480619
    [No Abstract]   [Full Text] [Related]  

  • 10. Response of 1alpha,25-dihydroxyvitamin D3 to hypocalcemia in human subjects.
    Bilezikian JP; Canfield RE; Jacobs TP; Polay JS; D'Adamo AP; Eisman JA; DeLuca HF
    N Engl J Med; 1978 Aug; 299(9):437-41. PubMed ID: 210383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs in current use: calcitriol.
    Aust Nurses J; 1980 Feb; 9(7):27-8. PubMed ID: 6900485
    [No Abstract]   [Full Text] [Related]  

  • 12. Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1alpha-hydroxylated derivatives.
    Kanis JA; Russell RG
    Br Med J; 1977 Jan; 1(6053):78-81. PubMed ID: 832019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective deficiency of 1,25-dihydroxycholecalciferol. A cause of isolated skeletal resistance to parathyroid hormone.
    Metz SA; Baylink DJ; Hughes MR; Haussler MR; Robertson RP
    N Engl J Med; 1977 Nov; 297(20):1084-90. PubMed ID: 198661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroid-responsive hypercalcemia with elevated serum 1-alpha, 25 dihydroxyvitamin D.
    Frame B; Parfitt AM
    Ann Intern Med; 1980 Sep; 93(3):449-51. PubMed ID: 7436165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum 1,25-dihydroxyvitamin D concentrations in the hypercalcemia of sarcoidosis: correction by glucocorticoid therapy.
    Chesney RW; Hamstra AJ; DeLuca HF; Horowitz S; Gilbert EF; Hong R; Borcherding W
    J Pediatr; 1981 Jun; 98(6):919-22. PubMed ID: 7229793
    [No Abstract]   [Full Text] [Related]  

  • 16. Ultrastructural evaluation of parathyroid glands and thyroid C cells of cattle fed Solanum malacoxylon.
    Collins WT; Capen CC; Döbereiner J; Tokarnia CH
    Am J Pathol; 1977 Jun; 87(3):603-14. PubMed ID: 869016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum 1,25-dihydroxyvitamin D in idiopathic hypercalciuria.
    Shen FH; Baylink DJ; Nielsen RL; Sherrard DJ; Ivey JL; Haussler MR
    J Lab Clin Med; 1977 Dec; 90(6):955-62. PubMed ID: 925484
    [No Abstract]   [Full Text] [Related]  

  • 18. Parathyroid hormone effect on 1,25-dihydroxyvitamin D in hypoparathyroidism.
    Mason RS; Lissner D; Posen S
    Ann Intern Med; 1980 Feb; 92(2 Pt 1):260. PubMed ID: 7352735
    [No Abstract]   [Full Text] [Related]  

  • 19. [A 1,25 dihydroxyvitamine D-like substance as the cause of calcinogenic effect of yellow oats (Trisetum flavescens)].
    Peterlik M; Regal DS; Köhler H
    Dtsch Tierarztl Wochenschr; 1977 Jul; 84(7):253-5. PubMed ID: 330134
    [No Abstract]   [Full Text] [Related]  

  • 20. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
    Hughes MR; Baylink DJ; Jones PG; Haussler MR
    J Clin Invest; 1976 Jul; 58(1):61-70. PubMed ID: 1084355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.